CTXR
Citius Pharmaceuticals Inc
3월 13일 4:00 PM ET (한국 3/14 05:00)
$0.96
+0.09 ▲ +10.92%
🌙 3월 13일 7:45 PM ET (한국 3/14 08:45)
$0.97
+0.01 ▲ +1.03%
| Index | - | P/E | - | EPS (ttm) | -2.89 | Insider Own | 2.37% | Shs Outstand | 0.02B | Perf Week | 15.22% |
| Market Cap | 0.02B | Forward P/E | 0.34 | EPS next Y | 68.07% | Insider Trans | - | Shs Float | 0.02B | Perf Month | 6.99% |
| Enterprise Value | 0.03B | PEG | - | EPS next Q | 0.39 | Inst Own | 7.69% | Short Float | 15.29% | Perf Quarter | -17.76% |
| Income | -0.04B | P/S | 5.46 | EPS this Y | 149.11% | Inst Trans | 5.72% | Short Ratio | 3.68 | Perf Half Y | -19.82% |
| Sales | 0.00B | P/B | 0.27 | EPS next 5Y | - | ROA | -27.49% | Short Interest | 3.34M | Perf YTD | 23.84% |
| Book/sh | 3.57 | P/C | 2.79 | EPS past 3/5Y | 16.24% 21.29% | ROE | -49.37% | 52W High | -61.2% ($2.48) | Perf Year | -37.92% |
| Cash/sh | 0.35 | P/FCF | - | Sales past 3/5Y | - | ROIC | -44.5% | 52W Low | 52.73% ($0.63) | Perf 3Y | -96.19% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | 50.13% | Gross Margin | 61.41% | Volatility(W/M) | 16.95% 12.43% | Perf 5Y | -97.98% |
| Dividend TTM | - | EV/Sales | 7.4 | Sales Y/Y TTM | - | Oper. Margin | -950.92% | ATR (14) | 0.11 | Perf 10Y | -99.9% |
| Dividend Ex-Date | - | Quick Ratio | 0.4 | EPS Q/Q | 70.67% | Profit Margin | -909.87% | RSI (14) | 60.74 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.99 | Sales Q/Q | - | SMA20 | 21.38% ($0.79) | Beta | 1.47 | Target Price | $6 |
| Payout | - | Debt/Eq | 0.02 | Earnings | 2000000 | SMA50 | 18% ($0.81) | Rel Volume | 1.45 | Prev Close | $0.87 |
| Employees | 23 | LT Debt/Eq | 0.01 | EPS/Sales Surpr. | -188.39% -78.1% | SMA200 | -17.18% ($1.16) | Avg Volume(3M) | 0.91M | Price | $0.96 |
| IPO | 2014/10/2 | Option/Short | Yes/No | Trades | 2003 | Volume | 1,318,670 | Change | 10.92% |
뉴스 로딩 중...